Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Shares Outstanding (Diluted Average) (2022 - 2025)

Historic Shares Outstanding (Diluted Average) for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $458.0 million.

  • GE HealthCare Technologies' Shares Outstanding (Diluted Average) fell 21.79% to $458.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $458.0 million, marking a year-over-year decrease of 21.79%. This contributed to the annual value of $458.0 million for FY2025, which is 21.79% down from last year.
  • GE HealthCare Technologies' Shares Outstanding (Diluted Average) amounted to $458.0 million in Q4 2025, which was down 21.79% from $458.0 million recorded in Q3 2025.
  • In the past 5 years, GE HealthCare Technologies' Shares Outstanding (Diluted Average) registered a high of $459.0 million during Q1 2024, and its lowest value of $454.0 million during Q1 2022.
  • Its 4-year average for Shares Outstanding (Diluted Average) is $457.3 million, with a median of $458.0 million in 2023.
  • In the last 5 years, GE HealthCare Technologies' Shares Outstanding (Diluted Average) soared by 88.11% in 2023 and then decreased by 21.79% in 2025.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' Shares Outstanding (Diluted Average) stood at $454.0 million in 2022, then grew by 0.88% to $458.0 million in 2023, then increased by 0.22% to $459.0 million in 2024, then dropped by 0.22% to $458.0 million in 2025.
  • Its last three reported values are $458.0 million in Q4 2025, $458.0 million for Q3 2025, and $459.0 million during Q2 2025.